Minjia Mo1, Shijie Wang1, Zun Chen1, Xiamusiye Muyiduli1, Shuojia Wang1, Yu Shen1, Bule Shao1, Minchao Li1, Danqing Chen2, Zexin Chen1, Yunxian Yu3. 1. Department of Public Health, and Department of Anesthesiology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. 2. Department of Obstetrics and Gynaecology, Woman's Hospital, School of Medicine, Zhejiang University, Hangzhou, China. 3. Department of Public Health, and Department of Anesthesiology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. yunxianyu@zju.edu.cn.
Abstract
BACKGROUND/ OBJECTIVES: Optimal doses of vitamin D (VitD) supplement in different populations are unclear. We aim to evaluate the relationship between VitD supplementation and post-intervention serum 25-hydroxyvitamin D [25(OH)D] concentration, to provide a recommended dosage of VitD for achieving an optimal 25(OH)D concentration for different populations. SUBJECTS/ METHODS: Literature search was conducted in Embase, etc. Randomized controlled trials about VitD supplemental intakes and their effect on 25(OH)D concentration were enrolled. The effect on 25(OH)D concentration between different supplementation doses in each population group was compared by meta-analysis. Multivariate meta-regression model is utilized to establish reference intake dosage of VitD. RESULTS: A total of 136 articles were included about children (3-17 years), adults (18-64 years), postmenopausal women, the elderly ( >64 years), pregnant, or lactating women. Overall, intervention groups obtained higher 25(OH)D concentration than controls and there was obvious dose-response effect between intake dose and 25(OH)D concentration. Baseline 25(OH)D concentration and age were significant indicators for 25(OH)D concentration. To reach sufficient 25(OH)D concentration (75 nmol/L), the recommended VitD supplemental intakes was 1340 and 2250 IU/day for children and pregnant women, 2519 and 797 IU/day for European adults aged 18-64 and 65-85 years, 729, 2026, and 1229 IU/day for adults in North America, Asia and Middle East and Africa, respectively. CONCLUSIONS: Regional- and age-specific recommended dosages of VitD supplements for population to achieve optimal 25(OH)D concentrations have been suggested.
BACKGROUND/ OBJECTIVES: Optimal doses of vitamin D (VitD) supplement in different populations are unclear. We aim to evaluate the relationship between VitD supplementation and post-intervention serum 25-hydroxyvitamin D [25(OH)D] concentration, to provide a recommended dosage of VitD for achieving an optimal 25(OH)D concentration for different populations. SUBJECTS/ METHODS: Literature search was conducted in Embase, etc. Randomized controlled trials about VitD supplemental intakes and their effect on 25(OH)D concentration were enrolled. The effect on 25(OH)D concentration between different supplementation doses in each population group was compared by meta-analysis. Multivariate meta-regression model is utilized to establish reference intake dosage of VitD. RESULTS: A total of 136 articles were included about children (3-17 years), adults (18-64 years), postmenopausal women, the elderly ( >64 years), pregnant, or lactating women. Overall, intervention groups obtained higher 25(OH)D concentration than controls and there was obvious dose-response effect between intake dose and 25(OH)D concentration. Baseline 25(OH)D concentration and age were significant indicators for 25(OH)D concentration. To reach sufficient 25(OH)D concentration (75 nmol/L), the recommended VitD supplemental intakes was 1340 and 2250 IU/day for children and pregnant women, 2519 and 797 IU/day for European adults aged 18-64 and 65-85 years, 729, 2026, and 1229 IU/day for adults in North America, Asia and Middle East and Africa, respectively. CONCLUSIONS: Regional- and age-specific recommended dosages of VitD supplements for population to achieve optimal 25(OH)D concentrations have been suggested.
Authors: Yong-Woo Park; Shankuan Zhu; Latha Palaniappan; Stanley Heshka; Mercedes R Carnethon; Steven B Heymsfield Journal: Arch Intern Med Date: 2003-02-24
Authors: Ibrahim M Kaddam; Adnan M Al-Shaikh; Bahaa A Abaalkhail; Khalid S Asseri; Yousef M Al-Saleh; Ali A Al-Qarni; Ahmed M Al-Shuaibi; Waleed G Tamimi; Abdelmoneim M Mukhtar Journal: Saudi Med J Date: 2017-04 Impact factor: 1.484
Authors: Kevin D Cashman; Kirsten G Dowling; Zuzana Škrabáková; Marcela Gonzalez-Gross; Jara Valtueña; Stefaan De Henauw; Luis Moreno; Camilla T Damsgaard; Kim F Michaelsen; Christian Mølgaard; Rolf Jorde; Guri Grimnes; George Moschonis; Christina Mavrogianni; Yannis Manios; Michael Thamm; Gert Bm Mensink; Martina Rabenberg; Markus A Busch; Lorna Cox; Sarah Meadows; Gail Goldberg; Ann Prentice; Jacqueline M Dekker; Giel Nijpels; Stefan Pilz; Karin M Swart; Natasja M van Schoor; Paul Lips; Gudny Eiriksdottir; Vilmundur Gudnason; Mary Frances Cotch; Seppo Koskinen; Christel Lamberg-Allardt; Ramon A Durazo-Arvizu; Christopher T Sempos; Mairead Kiely Journal: Am J Clin Nutr Date: 2016-02-10 Impact factor: 7.045
Authors: K Al-Dabhani; K K Tsilidis; N Murphy; H A Ward; P Elliott; E Riboli; M Gunter; I Tzoulaki Journal: Nutr Diabetes Date: 2017-04-10 Impact factor: 5.097
Authors: Nazik Elmalaika Husain; Ahmed Abdel Badie Suliman; Ismail Abdelrahman; Shahinaz A Bedri; Rasha M Musa; Hind E Osman; Ayda H Mustafa; Nahla Gafer; Ehab Farah; Ali Abdel Satir; Mohamed H Ahmed; Mugtaba Osman; Atif A Khalil; Abbas Agaimy Journal: J Family Med Prim Care Date: 2019-07
Authors: Teodora-Irina Adam-Bonci; Paraschiva Cherecheș-Panța; Eduard-Alexandru Bonci; Sorin Claudiu Man; Ancuța Cutaș-Benedec; Tudor Drugan; Raluca Maria Pop; Alexandru Irimie Journal: Int J Environ Res Public Health Date: 2020-09-09 Impact factor: 3.390
Authors: Benjamin Levy; Karen M O'Callaghan; Huma Qamar; Abdullah Al Mahmud; Alison D Gernand; M Munirul Islam; Daniel E Roth Journal: J Nutr Date: 2021-11-02 Impact factor: 4.798